By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Aegerion Pharmaceuticals, Inc. 

101 Main Street
Suite 1850
Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-500-7867 Fax: 908-541-1155


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
BioSpace (DHX)'s List of Five Companies to Watch in 2015: Aegerion (AEGR), AbbVie (ABBV), Tekmira (TKMR), Novartis AG (NVS), GlaxoSmithKline (GSK) 1/21/2015 4:06:07 PM
Aegerion Pharmaceuticals, Inc. (AEGR) Stays Mum as Top Investors Push to Oust CEO, Consider Sale 1/16/2015 2:56:17 PM
Aegerion Pharmaceuticals, Inc. (AEGR) Grants Stock Options Under Inducement Program 1/14/2015 7:18:13 AM
Aegerion Pharmaceuticals, Inc. (AEGR) Reports Preliminary 2014 Net Product Sales, Its Outlook For 2015 And Other Business Updates 1/12/2015 7:19:14 AM
Aegerion Pharmaceuticals, Inc. (AEGR) Completes Acquisition Of MYALEPT® 1/12/2015 7:05:54 AM
Aegerion Pharmaceuticals, Inc. (AEGR) To Present At The 33rd Annual J.P. Morgan Healthcare Conference 1/6/2015 8:48:02 AM
Aegerion Pharmaceuticals, Inc. (AEGR) Grants Stock Options Under Inducement Program 12/8/2014 8:42:05 AM
Aegerion Pharmaceuticals, Inc. (AEGR) To Present At The Deutsche Bank (DB) BioFest Conference 11/24/2014 2:51:28 PM
Aegerion Pharmaceuticals, Inc. (AEGR) Grants Stock Options Under Inducement Program 11/13/2014 7:33:06 AM
Aegerion Pharmaceuticals, Inc. (AEGR) Pays $325 Million Upfront For AstraZeneca PLC (AZN)'s Myalept™ 11/6/2014 6:13:40 AM
12345678910...
//-->